COMMITMENT TO SERVICES AGREEMENTCommitment to Services Agreement • March 13th, 2017 • Scynexis Inc • Pharmaceutical preparations
THIS AMENDMENT effective as of January 17, 2017 (this “Amendment”) amends that certain Commitment to Services Agreement dated as of July 17, 2015, as amended (the “Agreement”) by and between SCYNEXIS, Inc. and Accuratus Lab Services, Inc. n/k/a Avista Pharma Solutions, Inc. (the “Parties”). Capitalized terms not defined herein have the meaning set forth in the Agreement.
SECOND AMENDMENT TO TERMINATION AND LICENSE AGREEMENTTermination and License Agreement • March 13th, 2017 • Scynexis Inc • Pharmaceutical preparations
THIS SECOND AMENDMENT TO TERMINATION AND LICENSE AGREEMENT (the “Second Amendment”) is made and entered into as of December 21, 2016 by and between Merck Sharp & Dohme Corp., a New Jersey corporation with a place of business at One Merck Drive, Whitehouse Station, NJ 08889 (“Merck”) and SCYNEXIS, Inc., a Delaware corporation with a principal place of business at 101 Hudson Street, Suite 3610, Jersey City, NJ 07302 (“Scynexis”).
